Advertisement

Topics

Celgene amends protocols for midstage study of CAR T candidate bb2121

06:42 EDT 13 Jul 2018 | SmartBrief

Several changes to protocols have been reported by Celgene with regard to its midstage trial to test the efficacy of its chim -More

Original Article: Celgene amends protocols for midstage study of CAR T candidate bb2121

NEXT ARTICLE

More From BioPortfolio on "Celgene amends protocols for midstage study of CAR T candidate bb2121"

Advertisement
Quick Search
Advertisement
Advertisement